Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: SOBI Initiates Application To FDA For Sel-212

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    02/07/2024 07:12
    July 2 (Reuters) - Swedish Orphan Biovitrum AB (publ)
 SOBIV.ST :
    * SOBI INITIATES ROLLING BIOLOGICS LICENSE APPLICATION TO
FDA FOR
SEL-212 FOR THE POTENTIAL TREATMENT OF CHRONIC REFRACTORY GOUT

Source text for Eikon:  ID:nWkr1p8p2x 
Further company coverage:  SOBIV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news